AFG
JAZZ icon

Albion Financial Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Albion Financial Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2
Closed – – 578
2022
Q1 		$0 Hold
2
– – ﹤0.01% 630
2021
Q4 		$0 Hold
2
– – ﹤0.01% 653
2021
Q3 		$0 Hold
2
– – ﹤0.01% 534
2021
Q2 		$0 Buy
+2
New +$346 ﹤0.01% 524
2016
Q4 		– Sell
-2,823
Closed -$343K – 192
2016
Q3 		$343K Buy
2,823
+40
+1% +$5.39K 0.06% 144
2016
Q2 		$393K Buy
2,783
+15
+0.5% +$2.21K 0.07% 126
2016
Q1 		$361K Hold
2,768
– – 0.06% 128
2015
Q4 		$389K Sell
2,768
-70
-2% -$9.7K 0.07% 127
2015
Q3 		$377K Sell
2,838
-100
-3% -$17.2K 0.07% 129
2015
Q2 		$517K Buy
2,938
+35
+1% +$6.29K 0.09% 114
2015
Q1 		$502K Sell
2,903
-557
-16% -$95.6K 0.09% 111
2014
Q4 		$567K Sell
3,460
-422
-11% -$70K 0.1% 107
2014
Q3 		$623K Sell
3,882
-125
-3% -$19.2K 0.11% 101
2014
Q2 		$589K Buy
4,007
+100
+3% +$13.9K 0.1% 104
2014
Q1 		$542K Sell
3,907
-148
-4% -$22.3K 0.1% 106
2013
Q4 		$513K Hold
4,055
– – 0.1% 103
2013
Q3 		$373K Buy
4,055
+418
+11% +$33.7K 0.08% 115
2013
Q2 		$250K Buy
+3,637
New +$222K 0.06% 132

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Albion Financial Group's JAZZ Position: Q2 2022 in Review

Albion Financial Group sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2022, closing a stake of 2 shares.

Albion Financial Group first reported a position in JAZZ in Q2 2013 and held it in 18 quarters. The position peaked at $623K in Q3 2014. 468 funds tracked by Wall St. Rank hold JAZZ as of Q2 2022.

  • Albion Financial Group reported no remaining Jazz Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Albion Financial Group sold 2 Jazz Pharmaceuticals shares in Q2 2022.
  • Albion Financial Group first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • Albion Financial Group's Jazz Pharmaceuticals position peaked at $623K in Q3 2014.
  • 468 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2022.

Based on Albion Financial Group's 13F filing for Q2 2022, filed 29 Jul 2022.